Table 3. Prevalence of Side Effects After Treatment With CVL and PDL Systems .
Clinical Symptom | Observation Groups | |||
CVL
(nā =ā 635) |
PDL
(n = 607) |
|||
No. | % | No. | % | |
Crusts | 32 | 5.1 | 49 | 8.1 |
Edema, Hyperemia | 32 | 5.1 | 49 | 8.1 |
Vesicular rashes, Wetting | - | 33 | 5.4 | |
Depigmentation, Hyperpigmentation | - | 66 | 10.8 | |
Peeling | 17 | 2.6 | 16 | 2.7 |
Telangiectasia | 16 | 2.7 | ||
Total | 12.8 | 37.8 |